EP Patent

EP2646057A2 — Methods and systems for spatially identifying abnormal cells

Assigned to Lumicell Inc · Expires 2013-10-09 · 13y expired

What this patent protects

The present invention provides compositions and methods for imaging tumor resections.

USPTO Abstract

The present invention provides compositions and methods for imaging tumor resections.

Drugs covered by this patent

pegulicianine-acetate (PEGULICIANINE ACETATE)

Patent Metadata

Patent number: EP2646057A2
Jurisdiction: EP
Classification: —
Expires: 2013-10-09
Drug substance claim: No
Drug product claim: No
Assignee: Lumicell Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.